No abstract available
MeSH terms
-
Amyotrophic Lateral Sclerosis* / drug therapy
-
Amyotrophic Lateral Sclerosis* / genetics
-
Drug Approval
-
Endpoint Determination
-
Humans
-
Mutation
-
Oligonucleotides, Antisense* / therapeutic use
-
Superoxide Dismutase-1 / genetics
-
United States
-
United States Food and Drug Administration
Substances
-
Oligonucleotides, Antisense
-
SOD1 protein, human
-
Superoxide Dismutase-1
-
tofersen